Ligand validation:5IGP

ERY: ERYTHROMYCIN A

ERY is a Ligand Of Interest in 5IGP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5IGP_ERY_A_402	74%	3%	0.094	0.924	4.34	2.25	33	31	2	0	100%	1
5IGT_ERY_A_402	70%	4%	0.095	0.913	3.95	2.07	31	31	2	0	100%	1
3FRQ_ERY_A_195	93%	26%	0.067	0.96	1.5	1.62	7	17	1	0	100%	1
5IGY_ERY_A_403	90%	5%	0.073	0.954	3.77	1.96	29	26	0	0	100%	1
5IWU_ERY_A_404	89%	4%	0.068	0.946	3.92	1.94	31	26	0	0	100%	1
4M83_ERY_A_1400	87%	38%	0.083	0.954	1.25	1.26	6	6	0	0	100%	5
5IH0_ERY_A_404	86%	27%	0.086	0.953	1.73	1.37	14	12	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.